Nitric oxide-donating aspirin induces G2/M phase cell cycle arrest in human cancer cells by regulating phase transition proteins
Open Access
- 30 April 2012
- journal article
- Published by Spandidos Publications in International Journal of Oncology
- Vol. 41 (1) , 325-330
Abstract
NO-aspirin (NO-ASA), consisting of aspirin and a nitric oxide-releasing group, is safer than aspirin and effective in colon cancer prevention. Here, we examined the mechanism of action of NO-ASA by focusing primarily on its effects on the cell cycle. NO-ASA reduced the growth of several cell lines from colon, pancreas, skin, cervix and breast cancer much more potently than aspirin, with 24-h IC50 values of 133-268 µM, while those of ASA were >1,000 µM. NO-ASA elevated the intracellular levels of reactive oxygen species, generating a state of oxidative stress. In all cell lines examined, NO-ASA induced cell cycle arrest in the G2/M phase transition accompanied by altered expression of G2/M transition-related proteins. In SW480 colon cancer cells NO-ASA modulated proteins controlling this transition. Thus, it markedly increased the levels of cyclin B1, decreased the expression of cyclin D1 and Cdc25C, and increased the Thr14/Tyr15-phosphorylation of Cdk1 while leaving unchanged its protein levels. These changes, including the G2/M arrest, were prevented by pretreating the cells with the anti-oxidant N-acetyl-cysteine, indicating that redox signaling is likely responsible for the cell cycle changes, a conclusion consistent with the known redox regulation of these proteins. Collectively, these results confirm the profound cytokinetic effect of NO-ASA and provide strong evidence that it regulates cell cycle transitions through its ability to induce oxidative stress, which activates redox signaling in the target cell.Keywords
This publication has 27 references indexed in Scilit:
- NO-donating aspirin inhibits intestinal carcinogenesis in Min (APCMin/+) miceBiochemical and Biophysical Research Communications, 2004
- Ways of dying: multiple pathways to apoptosisGenes & Development, 2003
- Catalytic and Chemical Competence of Regulation of Cdc25 Phosphatase by Oxidation/ReductionBiochemistry, 2003
- Effect of H2O2 on cell cycle and survival in DNA mismatch repair-deficient and -proficient cell linesCancer Letters, 2003
- Redox regulation of the G1 to S phase transition in the mouse embryo fibroblast cell cycle.2003
- Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: A proof of concept endoscopic studyGastroenterology, 2003
- Nonsteroidal Anti-inflammatory Drugs as Anticancer Agents: Mechanistic, Pharmacologic, and Clinical IssuesJNCI: Journal of the National Cancer Institute, 2002
- The Role of NSAIDs in the Prevention of Colon CancerCancer Investigation, 2002
- Effect of Glutathione Depletion on Antitumor Drug Toxicity (Apoptosis and Necrosis) in U-937 Human Promonocytic CellsJournal of Biological Chemistry, 2001
- Antitumor Imidazolyl Disulfide IV-2 Causes Irreversible G2/M Cell Cycle Arrest without Hyperphosphorylation of Cyclin-Dependent Kinase Cdk1The Journal of Pharmacology and Experimental Therapeutics, 2000